Finance

Lists
LNSR:NASDAQ
LENSAR Inc
6,70 US$
+0,45%
(+0,030) 1D
6,70 US$
0,00% (0,00)
After hours
Closed: 6 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LNSR...
Open
6,66 US$
High
6,80 US$
Low
6,58 US$
Mkt. cap
83,30 მლნ.
Avg. vol.
72,84 ათ.
Volume
33,93 ათ.
P/E ratio
7,46
52-wk high
12,94 US$
52-wk low
4,95 US$
EPS
0,90 US$
Beta
0,95
Shares outstanding
12,29 მლნ.
No. of employees
150
Open
6,66 US$
High
6,80 US$
Low
6,58 US$
Mkt. cap
83,30 მლნ.
Avg. vol.
72,84 ათ.
Volume
33,93 ათ.
P/E ratio
7,46
52-wk high
12,94 US$
52-wk low
4,95 US$
EPS
0,90 US$
Beta
0,95
Shares outstanding
12,29 მლნ.
No. of employees
150
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
5 საათის წინ
LENSAR stock highlights 18 percent Q2 revenue growth
Stock Traders Daily
Stock Traders Daily
·
8 საათის წინ
(LNSR) Movement Within Algorithmic Entry Frameworks
AD HOC NEWS
AD HOC NEWS
·
2 დღის წინ
LENSAR stock gained 2.74 percent as analysts weigh growth strategically
About LENSAR Inc
CEO-
Employees150
Founded2004
Headquartersორლანდო, ფლორიდა, ამერიკის შეერთებული შტატები
SectorMedical device
Websitelensar.com
Analyst ratings
Based on 3 analysts giving stock ratings to LNSR in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for LNSR in the last 3 months.
Highest
Current 6,70 US$
13,00 US$ (+94,03%)
Average
11,33 US$ (+69,10%)
Lowest
10,00 US$ (+49,25%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alexander Nowak
Lucid Capital
Buy
Initiated
11,00 US$
+64,2%
09/28/2026
Frank Takkinen
Lake Street
Buy
Reiterated
13,00 US$
+94%
08/25/2026
Ryan Zimmerman
BTIG
Buy
Reiterated
10,00 US$
+49,3%
08/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
14,32 მლნ.
16,02 მლნ.
13,43 მლნ.
16,50 მლნ.
Cost of goods sold
8,28 მლნ.
9,09 მლნ.
7,05 მლნ.
6,72 მლნ.
Cost of revenue
8,28 მლნ.
9,09 მლნ.
7,05 მლნ.
6,72 მლნ.
Research and development expenses
1,37 მლნ.
1,30 მლნ.
1,38 მლნ.
1,27 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,74 მლნ.
24,00 მლნ.
6,90 მლნ.
6,14 მლნ.
Operating expense
8,34 მლნ.
25,53 მლნ.
8,52 მლნ.
7,64 მლნ.
Total operating expenses
16,62 მლნ.
34,62 მლნ.
15,56 მლნ.
14,36 მლნ.
Operating income
-2,30 მლნ.
-18,59 მლნ.
-2,13 მლნ.
2,13 მლნ.
Other non operating income
3,85 მლნ.
3,44 მლნ.
24,07 მლნ.
1,38 მლნ.
EBT including unusual items
-3,71 მლნ.
-1,46 მლნ.
36,33 მლნ.
3,54 მლნ.
EBT excluding unusual items
1,56 მლნ.
-15,13 მლნ.
21,96 მლნ.
3,54 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,71 მლნ.
-1,46 მლნ.
36,33 მლნ.
3,54 მლნ.
Net profit margin
-25,94%
-9,10%
270,57%
21,43%
Earnings per share
-0,11
-0,11
-0,20
0,10
Interest and investment income
20,00 ათ.
23,00 ათ.
19,00 ათ.
17,00 ათ.
Interest expense
-
-
-
-
Net interest expenses
20,00 ათ.
23,00 ათ.
19,00 ათ.
17,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,15 მლნ.
-17,42 მლნ.
-1,00 მლნ.
3,24 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები